Exscientia Plc Stock Price, News & Analysis
Company Description
Exscientia Plc (NASDAQ: EXAI) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector. The company has a market capitalization of $633.2M, ranking #3,225 among all listed U.S. companies by market cap.
EXAI stock has declined 16.8% over the past year. Shares last traded at $4.84.
This page provides a comprehensive overview of EXAI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Exscientia Plc (EXAI) stock last traded at $4.84. Over the past 12 months, the stock has lost 16.8%. At a market capitalization of $633.2M, EXAI is classified as a small-cap stock with approximately 129.3M shares outstanding.
Latest News
Exscientia Plc has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include conferences, clinical trial, AI, acquisition, management. View all EXAI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
EXAI Company Profile & Sector Positioning
Exscientia Plc (EXAI) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.